These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29073897)

  • 1. A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro.
    Yang T; Li H; Yue L; Song X; Xie T; Ma S; Meng H; Zhang Y; He X; Long R; Yang R; Luo F; Xie Z; Li Q
    Virol J; 2017 Oct; 14(1):206. PubMed ID: 29073897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
    Wang KT; Lin SJ; Wang HC; Chen PC; Lin JJ; Chiang JR; Chang CL; Shih DY; Lo CF; Wang DY
    Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
    Liu CC; Chow YH; Chong P; Klein M
    Vaccine; 2014 Oct; 32(47):6177-82. PubMed ID: 25218294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.
    Arita M; Nagata N; Iwata N; Ami Y; Suzaki Y; Mizuta K; Iwasaki T; Sata T; Wakita T; Shimizu H
    J Virol; 2007 Sep; 81(17):9386-95. PubMed ID: 17567701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
    Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
    Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
    Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
    Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
    Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
    Liu P; Yuan Y; Cui B; Huo Y; Bian L; Chen L; Liu S; Wang C; Xu Y; Tedcastle A; Gao F; Mao Q; Martin J; Liang Z
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33919184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
    Klein MH
    Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine.
    Li J; Liu G; Liu X; Yang J; Chang J; Zhang W; Yu XF
    Viruses; 2015 Jul; 7(7):3891-909. PubMed ID: 26193302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys.
    Dong C; Wang J; Liu L; Zhao H; Shi H; Zhang Y; Jiang L; Li Q
    Hum Vaccin; 2010 Dec; 6(12):1028-37. PubMed ID: 21150270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
    In HJ; Lim H; Lee JA; Lee SR; Jin YB; Jeong KJ; Hyeon JY; Yoo JS; Lee JW; Choi YK; Lee SW
    PLoS One; 2018; 13(10):e0202552. PubMed ID: 30278051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological evaluation and comparison of different EV71 vaccine candidates.
    Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
    Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.